Kolon Tissuegeneincis A Clinical Stage Bio Pharmaceutical Company Based In Marylandusathat Specializes In Developing Regenerative Therapiesparticularly In Cell Therapyfounded In 1999The Company Is Part Of The Kolon Group And Is Dedicated To Providing Safe And Effective Treatments For Orthopedic Diseases And Degenerative Disorders The Company Focuses On Cell Based Therapieswith Its Lead Product Candidate Being Invossatg C A Cell And Gene Therapy Designed To Treat Osteoarthritis Of The Kneethis Innovative Therapy Involves An Injectable Dose Of Allogeneic Primary Human Chondrocyteskolon Tissuegene Also Has A Pipeline Of Therapies Targeting Other Musculoskeletal Disordersincluding Rheumatoid Arthritis And Spinal Disc Issuesand Is Exploring Applications In Veterinary Medicine With A Unique Technology Platform Developed Over Two Decadeskolon Tissuegene Has Secured Several Patents Related To Its Gene Therapy Innovationsthe Company Is Led By President And Ceo Moon Jong Noh And Has Established Partnerships To Further Its Mission In Regenerative Medicine
